Evaluation of the VITEK 2 cards for identification and antimicrobial susceptibility testing of non-glucose-fermenting Gram-negative bacilli

APMIS

Volumn 117, Issue 4, 2009, Pages 241-247

  Hsieh, Wen Shyang ^a   Sung, Ling Ling ^a   Tsai, Kun Chou ^a   Ho, Hsin Tsung ^a,b  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NURSING AND MANAGEMENT COLLEGE   (Taiwan)

Author keywords

AST; ID; Non glucose fermenting GNB; Vitek 2

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BURKHOLDERIA CEPACIA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GRAM NEGATIVE BACTERIUM; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; REAGENT KITS, DIAGNOSTIC;

EID: 63449102396     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02436.x     Document Type: Article

References (14)

1. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 15th informational supplement, M100-S15, 2005.
2. Sung LL, Yang DI, Hung CC, Ho HT. Evaluation of autoSCAN-W/A and the Vitek GNI+AutoMicrobic system for identification of non-glucose-fermenting gram-negative bacilli. J Clin Microbiol 2000 31 : 3165 9.
3. Funke G, Monnet D, deBernardis C, von Graevenitz A, Freney J. Evaluation of the VITEK 2 system for rapid identification of medically relevant gram-negative rods. J Clin Microbiol 1998 36 : 1948 52.
4. Jossart MF, Courcol RJ. Evaluation of an automated system for identification of Enterobacteriaceae and nonfermenting bacilli. Eur J Clin Microbiol Infect Dis 1999 18 : 902 7.
5. Funke G, Funke-Kissling P. Evaluation of the new VITEK 2 Card for identification of clinically relevant gram-negative rods. J Clin Microbiol 2004 42 : 4067 71.
6. Funke G, Funke-Kissling P. Performance of the new VITEK 2 card for identification of medically relevant gram-positive cocci in a routine clinical laboratory. J Clin Microbiol 2005 3 : 84 8.
7. Weyant RS, Moss CW, Weaver RE, Hollis DG, Jordan JG, Cook EC, et al. Identification of Unusual Pathogenic Gram-Negative Aerobic and Facultatively Anaerobic Bacteria, 2nd ed. Baltimore, MD : The Williams & Wilkins Co., 1996.
8. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH. Man Clin Microbiol, 8th ed. Washington, DC : ASM press, 2003.
9. Joyanes P, del Carmen Conejo M, Martínez-Martínez L, Perea E. Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J Clin Microbiol 2001 39 : 3247 53.
10. Ling TKW, Tam PC, Liu ZK, Cheng AFB. Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates. J Clin Microbiol 2001 39 : 2964 6.
11. Gavin PJ, Warren JR, Obias AA, Collins SM, Peterson LR. Evaluation of the Vitek 2 system for rapid identification of clinical isolates of gram-negative bacilli and members of the family Streptococcaceae. Eur J Clin Microbiol Infect Dis 2002 21 : 869 74.
12. Barenfanger J, Drake C, Kacich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 1999 37 : 1415 8.
13. Doern G, Vautour R, Gaudet M, Levy B. Clinical impact of rapid in vitro susceptibility testing and bacterial identification. J Clin Microbiol 1994 32 : 1757 62.
14. National Committee for Clinical Laboratory Standards. Development of in vitro susceptibility testing criteria and quality control parameters. Approved guideline, M23-A, 1994.